EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SERS ‐Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia

Anamaria Bancos, Stefania D Iancu, Vlad Moisoiu, Alexandra Ghiaur, Adrian Bogdan Tigu, Cristina Buran, Georgiana Ion, Camelia Stancioaica, Bogdan Ionescu, Mihaela Dragomir, Codruta F Buldus, Diana Cenariu und 6 weitere

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70244 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Anamaria Bancos und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology-Medfuture Research Center for Advances Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania. Hauptthemen laut MEDLINE: Leukemia, Promyelocytic, Acute, DNA Methylation, Neoplasm, Residual, Spectrum Analysis, Raman. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Romanian Ministry of Research and Innovation, Babeș-Bolyai University, Iuliu Hatieganu University of Medicine and Pharmacy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute promyelocytic leukaemia (APL) is a type of acute myeloid leukaemia characterised by the reciprocal translocation t(15;17), which offers a unique possibility for measurable residual disease (MRD) monitoring by PCR amplification of the PML‐RARA transcripts. Surface‐enhanced Raman scattering (SERS) is a laser molecular spectroscopy technique that allows the rapid analysis of changes in the DNA methylation pattern associated with malignant transformation. In this study involving 49 DNA samples from bone marrow aspirations from patients with APL, we showed that the DNA from MRD‐positive samples exhibited lower SERS intensities of the band at 730 cm −1 attributed to adenine. Next, we used the scores derived from principal component analysis (PCA) as input data for machine learning algorithms trained to categorise SERS spectra based on MRD status. The results showed that the highest classification accuracy was achieved by logistic regression, yielding an area under the ROC curve (AUROC) of 0.90. In addition, PCA showed that samples corresponding to patients with FLT3‐ITD mutations had a tendency for unsupervised clustering irrespective of MRD status. These results suggest that SERS analysis of DNA represents a promising method for the MRD monitoring of APL patients. Future validation of these findings in large prospective studies is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Promyelocytic, AcuteDNA MethylationNeoplasm, ResidualSpectrum Analysis, RamanHumansMaleFemalePrincipal Component AnalysisAdultMiddle AgedROC CurveAgedfms-Like Tyrosine Kinase 3Young AdultAdolescent

Stichwörter der Autor:innen

SERSacute promyelocytic leukaemiaminimal residual disease

Substanzen

fms-Like Tyrosine Kinase 3

Autor:innen und Institutionen

  • Department of Hematology-Medfuture Research Center for Advances Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Faculty of Physics, Babeș-Bolyai University, Cluj-Napoca, Romania.
  • Department of Leukemia, Fundeni Clinical Institute, Bucharest, Romania.
  • Medfuture Research Center for Advances Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Bucharest, Romania.
  • Faculty of Physical Education and Sport, Babeș-Bolyai University, Cluj-Napoca, Romania.

ORCID-Profile: Daniel Coriu, Ciprian Tomuleasa

Förderung

  • Romanian Ministry of Research and Innovation
  • Babeș-Bolyai University
  • Iuliu Hatieganu University of Medicine and Pharmacy
  • Iuliu Hatieganu University
  • Romanian Government
  • Romanian Academy of Scientists
  • European Hematology Association
  • Romanian Research Ministry

Zitieren

APA

Bancos, A., Iancu, S. D., Moisoiu, V., Ghiaur, A., Tigu, A. B., Buran, C., Ion, G., Stancioaica, C., Ionescu, B., Dragomir, M., Buldus, C. F., Cenariu, D., Nistor, M., Kegyes, D., Gulei, D., Leopold, N., Coriu, D., & Tomuleasa, C. (2025). SERS ‐Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70244

Vancouver

Bancos A, Iancu SD, Moisoiu V, Ghiaur A, Tigu AB, Buran C, et al. SERS ‐Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70244

BibTeX
@article{Bancos2025,
  author = {Bancos, Anamaria and Iancu, Stefania D and Moisoiu, Vlad and Ghiaur, Alexandra and Tigu, Adrian Bogdan and Buran, Cristina and Ion, Georgiana and Stancioaica, Camelia and Ionescu, Bogdan and Dragomir, Mihaela and Buldus, Codruta F and Cenariu, Diana and Nistor, Madalina and Kegyes, David and Gulei, Diana and Leopold, Nicolae and Coriu, Daniel and Tomuleasa, Ciprian},
  title = {SERS ‐Based Assessment of DNA Methylation for the Evaluation of Measurable Residual Disease in Acute Promyelocytic Leukaemia},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70244}
}
Kostenlos starten →